HealthEquity Files 8-K
Ticker: HQY · Form: 8-K · Filed: Apr 15, 2024 · CIK: 1428336
| Field | Detail |
|---|---|
| Company | Healthequity, INC. (HQY) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $555 million, $84.9 million, $50.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, regulation-fd, exhibits
Related Tickers: HQY
TL;DR
HealthEquity filed an 8-K on April 15th for an April 11th event. Details pending.
AI Summary
HealthEquity, Inc. filed an 8-K on April 15, 2024, to report an event that occurred on April 11, 2024. The filing is a Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates HealthEquity is disclosing information or submitting exhibits to the SEC, which could contain material updates for investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific negative or positive financial disclosures.
Key Players & Entities
- HEALTHEQUITY, INC. (company) — Registrant
- April 11, 2024 (date) — Earliest event date
- April 15, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 15 West Scenic Pointe Drive Suite 100 Draper , Utah 84020 (address) — Principal Executive Offices
FAQ
What specific event triggered this 8-K filing for HealthEquity?
The filing indicates an event occurred on April 11, 2024, but the specific nature of the event is not detailed in the provided excerpt.
What is the purpose of this 8-K filing?
The filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and includes Regulation FD Disclosure and Financial Statements and Exhibits.
When was this 8-K report filed with the SEC?
The report was filed on April 15, 2024.
Where are HealthEquity's principal executive offices located?
HealthEquity's principal executive offices are located at 15 West Scenic Pointe Drive, Suite 100, Draper, Utah 84020.
What is HealthEquity's SEC file number?
HealthEquity's SEC file number is 001-36568.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-04-15 16:01:22
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share HQY The NASDAQ Global Select
- $555 million — ed, with approximately 134,000 HSAs and $555 million of HSA assets transferring to HealthEqu
- $84.9 million — y paid the applicable purchase price of $84.9 million using $50.0 million of borrowings under
- $50.0 million — e purchase price of $84.9 million using $50.0 million of borrowings under its revolving credi
Filing Documents
- hqy-20240411.htm (8-K) — 23KB
- 0001428336-24-000018.txt ( ) — 147KB
- hqy-20240411.xsd (EX-101.SCH) — 2KB
- hqy-20240411_lab.xml (EX-101.LAB) — 22KB
- hqy-20240411_pre.xml (EX-101.PRE) — 13KB
- hqy-20240411_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure As disclosed previously, on September 18, 2023, HealthEquity entered into a Custodial Transfer and Asset Purchase Agreement with Conduent Business Services, LLC, related to the transfer to HealthEquity of Conduent's health savings account ("HSA") portfolio in a series of three tranches. On April 11, 2024, the second of the three HSA asset transfers occurred, with approximately 134,000 HSAs and $555 million of HSA assets transferring to HealthEquity's custody. In connection with this transfer, HealthEquity paid the applicable purchase price of $84.9 million using $50.0 million of borrowings under its revolving credit facility, with the remainder paid using cash on hand.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (formatted in Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHEQUITY, INC. Date: April 15, 2024 By: /s/ James Lucania Name: James Lucania Title: Executive Vice President and Chief Financial Officer